Headlines

---

Recent Headlines

	Reminder: Merck to Hold 2011 Full-Year and Fourth...	Merck Financial News
	New FDA Approved Labeling For VYTORIN (Ezetimibe/...	Merck Product News
	Merck to Present at the 30th Annual J.P. Morgan H...	Merck Financial News
	FDA Approves Merck?s ISENTRESS (raltegravir) for ...	Merck Product News
	Merck to Present at Goldman Sachs 2012 Healthcare...	Merck Financial News
	Merck and the ADAP Crisis Task Force Announce New...	Merck Product News
	Merck Announces Initiation of Clinical Developmen...	Merck Product News
	Merck Announces Results of ZOLINZA (vorinostat) P...	Merck Product News
	Merck Resolves Vioxx® Litigation in Canada	Merck Corporate News
	Merck Establishes New MSD R&D Asia Headquarters	Merck Research and Development News
	Merck Establishes New MSD R&D Asia Headquarters	Merck Corporate News
	Merck Resolves Previously Disclosed Seven-Year In...	Merck Corporate News
	Data from TRACER Study of Vorapaxar, Merck's Inve...	Merck Research and Development News
	Merck Executing on Strategy to Position Company f...	Merck Corporate News
	Merck Highlights Pipeline Progress and Showcases ...	Merck Research and Development News
	Merck to Present at the 2011 Credit Suisse Health...	Merck Financial News
	Merck Launches NEXPLANON® (etonogestrel impla...	Merck Product News
	Interim Data for Merck's VICTRELIS™ (bocepr...	Merck Product News
	FDA Advisory Committee Unanimously Recommends App...	Merck Product News
	Merck Announces Dates for R&D and Business Briefi...	Merck Financial News
	Merck Announces Third Quarter 2011 Financial Resu...	Merck Financial News
	New England Journal of Medicine Publishes Additio...	Merck Product News
	CDC Advisory Committee on Immunization Practices ...	Merck Product News
	Merck Announces Retirement of Chairman and Former...	Merck Corporate News
	FDA Accepts New Drug Application Filing for Ridaf...	Merck Research and Development News
	Merck Adds New Medication Adherence Resources to ...	Merck Corporate News
	Merck Wins Another Federal Bellwether Trial Regar...	Merck Corporate News
	Merck to Hold Third-Quarter 2011 Sales and Earnin...	Merck Financial News
	Merck Sells Its Interest in Johnson & Johnson-Mer...	Merck Corporate News
	Merck Names Cuong Viet Do as Chief Strategy Offic...	Merck Corporate News
	Merck Joins Global Fight to Help Save Women's Liv...	Merck Corporate News
	Merck to Present at Morgan Stanley Global Healthc...	Merck Financial News
	Merck to Present at Bank of America Merrill Lynch...	Merck Financial News
	Merck and BGI Establish Strategic Collaboration F...	Merck Research and Development News
	New Data on Odanacatib, Merck's Phase III Investi...	Merck Research and Development News
	Merck and ARIAD Announce European Medicines Agenc...	Merck Research and Development News
	Merck to Acquire Rights to Vernakalant i.v. in Ca...	Merck Research and Development News
	Merck Announces Fourth Quarter 2011 Dividend	Merck Financial News
	Merck to Participate in New Research Efforts to E...	Merck Research and Development News
	Merck and Hanwha Chemical Corporation Establish G...	Merck Research and Development News